And clinical failure criteria, they were counted as immunological failures. Where CDM participants had both WHO 4 and WHO 3 events, they were counted as WHO 4 failures. Categorical variables were compared using chi-squared/exact tests, continuous variables using t-tests/rank-sum tests. To inform clinical practice when `tiebreaker' VL tests are not available to confirm that clinical/immunological f